ICAGEN
Icagen, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets. It develops ICA-105665 that is in Phase I single dose escalation study in healthy volunteers for epilepsy and neuropathic pain; and Senicapoc, which is in Phase I multiple dose study in healthy volunteers for the treatment of asthma. The company also conducts ongoing drug discovery programs on new therapeutics for pain and inflammatory disorders. Icagen has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma, Inc.; and Pfizer, Inc.
ICAGEN
Industry:
Biotechnology Health Care Medical
Founded:
1992-01-01
Address:
Durham, North Carolina, United States
Country:
United States
Website Url:
http://www.icagen.com
Total Employee:
11+
Status:
Active
Contact:
(919)941-5206
Email Addresses:
[email protected]
Total Funding:
29.49 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Domain Not Resolving Apache Microsoft Exchange Online Amazon
Similar Organizations
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
Cabaletta Bio
Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.
Foundation Medicine
Foundation medicine is a molecular information company developing clinical diagnostic tests that facilitates personalized cancer therapies.
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Current Employees Featured
Founder
Stock Details
Investors List
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation investment in Grant - ICAgen
Pfizer Venture Investments
Pfizer Venture Investments investment in Post-IPO Equity - ICAgen
Venrock
Venrock investment in Venture Round - ICAgen
Official Site Inspections
http://www.icagen.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
